KCG
CHTP

Knight Capital Group’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

Knight Capital Group’s Portfolio CHTP Stock Details CHTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$108K Buy
+47,056
New +$95.1K ﹤0.01% 2929

Other funds holding CHTP

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Knight Capital Group's CHTP Position: Q2 2013 in Review

Knight Capital Group opened a new position in CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q2 2013: 47,056 shares worth $108K. The stake represents ﹤0.01% of the portfolio and ranks #2929 among its holdings.

61 funds tracked by Wall St. Rank hold CHTP as of Q2 2013.

  • Knight Capital Group held 47,056 shares of CHELSEA THERAPEUTICS INT'L LTD worth $108K as of Q2 2013.
  • CHELSEA THERAPEUTICS INT'L LTD was a new Knight Capital Group position in Q2 2013.
  • CHELSEA THERAPEUTICS INT'L LTD made up ﹤0.01% of Knight Capital Group's portfolio in Q2 2013, its #2929 holding.
  • 61 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.